Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 511

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures

Open access
van den Bogaard, Veerle A.B., Ta, Bastiaan D.P., van der Schaaf, Arjen, Bouma, Angelique B., Middag, Astrid M.H., Bantema-Joppe, Enja J., van Dijk, Lisanne V., van Dijk-Peters, Femke B.J., Marteijn, Laurens A.W., de Bock, Gertruida H., Burgerhof, Johannes G.M., Gietema, Jourik A., Langendijk, Johannes A., Maduro, John H., Crijns, Anne P.G·2017·Journal of Clinical Oncology

Abstract

Purpose: A relationship between mean heart dose (MHD) and acute coronary event (ACE) rate was reported in a study of patients with breast cancer (BC). The main objective of our cohort study was to validate this relationship and investigate if other dose-distribution parameters are better predictors for ACEs than MHD. Patients and Methods: The cohort consisted of 910 consecutive female patients with BC treated with radiotherapy (RT) after breast-conserving surgery. The primary end point was cumulative incidence of ACEs within 9 years of follow-up. Both MHD and various dose-distribution parameters of the cardiac substructures were collected from three-dimensional computed tomography planning data. Results: The median MHD was 2.37 Gy (range, 0.51 to 15.25 Gy). The median follow-up time was 7.6 years (range, 0.1 to 10.1 years), during which 30 patients experienced an ACE. The cumulative incidence of ACE increased by 16.5% per Gy (95% CI, 0.6 to 35.0; P = .042). Analysis showed that the volume of the left ventricle receiving 5 Gy (LV-V5) was the most important prognostic dose-volume parameter. The most optimal multivariable normal tissue complication probability model for ACEs consisted of LV-V5, age, and weighted ACE risk score per patient (c-statistic, 0.83; 95% CI, 0.75 to 0.91). Conclusion: A significant dose-effect relationship was found for ACEs within 9 years after RT. Using MHD, the relative increase per Gy was similar to that reported in the previous study. In addition, LV-V5 seemed to be a better predictor for ACEs than MHD. This study confirms the importance of reducing exposure of the heart to radiation to avoid excess risk of ACEs after radiotherapy for BC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2016.69.8480

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Metadata

Authors
van den Bogaard, V. A. B., Ta, B. D. P., van der Schaaf, A., Bouma, A. B., Middag, A. M. H., Bantema-Joppe, E. J., van Dijk, L. V., van Dijk-Peters, F. B. J., Marteijn, L. A. W., de Bock, G. H., Burgerhof, J. G. M., Gietema, J. A., Langendijk, J. A., Maduro, J. H., & Crijns, A. P. G.
Venue
Journal of Clinical Oncology
Published
2017-04-10
Volume
35
Issue
11
Pages
1171-1178
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2574924994
Cited by
511
References
35
FWCI
35.18
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures. https://app.cochat.ai/papers/10.1200/jco.2016.69.8480
The paper
van den Bogaard, V. A. B., Ta, B. D. P., van der Schaaf, A., Bouma, A. B., Middag, A. M. H., Bantema-Joppe, E. J., van Dijk, L. V., van Dijk-Peters, F. B. J., Marteijn, L. A. W., de Bock, G. H., Burgerhof, J. G. M., Gietema, J. A., Langendijk, J. A., Maduro, J. H., & Crijns, A. P. G. (2017). Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2016.69.8480

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.